Document Download
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer
Author / Organization: Maurice Pérol, Nick Pavlakis, Evgeny Levchenko, Marco Platania, Julio Oliveira, Silvia Novello, Rita Chiari, Teresa Moran, Emmanuel Mitry, Eveline Nüesch, Ting Liu, Bogdana Balas, Krzysztof Konopa, Solange Peters
| File Format | PDF (Portable Document Format) |
|---|---|
| Publication Year | 2019 |
| Source Host |
HAL Open Science
(hal.science)
|
| License / Terms | Open Access / Creative Commons |
Ready for Immediate Access
Your selected document is ready for instant access with zero mandatory waiting period.
Alternative Options:
Download via MainReads Proxy
Read Online in PDF.js Viewer
Open Source Website »
Linking & Access Policy: MainReads provides direct outbound links to documents and educational resources hosted by original source repositories, universities, and open libraries. Downloads are never made conditional on advertisements or user registrations. If you encounter an inaccessible or broken resource link, please use the Report Broken Link feature on the catalog page.